A synergistic multiparametric MRI strategy for FAPα-targeted tumor fibrosis based on NaGdF4@PEG-FAPI nanoprobes

Yuqiang Ma1, Ni Zhang2, Shuai Wu1

  • 1College of Life Science and technology, Beijing University of chemical technology, Beijing 100029, China. houyi@iccas.ac.cn.

Nanoscale
|April 13, 2026
PubMed

Insights

Researchers developed a novel nanoprobe targeting fibroblast activation protein α (FAPα) for advanced MRI detection of tumor fibrosis. This FAPα-targeted probe enables precise, multiparametric imaging for early cancer diagnosis.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Medical Imaging

Background:

  • Tumor-associated fibrosis, driven by cancer-associated fibroblasts (CAFs), is crucial in tumor progression and immune evasion.
  • Fibroblast activation protein α (FAPα) is highly expressed in solid tumors but not normal tissues, making it an ideal diagnostic target.

Purpose of the Study:

  • To develop a FAPα-targeted nanoprobe for multiparametric MRI diagnosis of tumor fibrosis.
  • To evaluate the nanoprobe's performance in characterizing tumors and detecting fibrotic lesions.

Main Methods:

  • Engineered a dual-mode T1/T2 MRI nanoprobe, NaGdF4@PEG-FAPI, targeting FAPα.
  • Conducted extensive biosafety evaluations to confirm biocompatibility.
  • Assessed nanoprobe performance in A549 subcutaneous tumor models using Dynamic Contrast-Enhanced (DCE) MRI, T1-weighted imaging (T1WI), and T2-weighted imaging (T2WI).

Main Results:

  • The NaGdF4@PEG-FAPI nanoprobe demonstrated excellent biocompatibility.
  • It provided high-resolution visualization of tumor vasculature in DCE-MRI, outperforming Gd-DTPA and a non-targeted control.
  • Synergistic T1-weighted enhancement and T2-weighted darkening confirmed tumor localization, with FAPI-mediated targeting ensuring prolonged retention and enhanced signal.

Conclusions:

  • The developed FAPα-targeted nanoprobe offers a robust platform for multiparametric, high-sensitivity tumor diagnosis.
  • This approach shows significant potential for early detection of tumor fibrosis via MRI.
  • The nanoprobe facilitates comprehensive tumor characterization through dual-mode T1/T2 MRI.

Related Concept Videos